A detailed history of Fox Hill Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Fox Hill Wealth Management holds 10,350 shares of LLY stock, worth $8.16 Million. This represents 5.05% of its overall portfolio holdings.

Number of Shares
10,350
Previous 10,646 2.78%
Holding current value
$8.16 Million
Previous $9.64 Billion 4.87%
% of portfolio
5.05%
Previous 5.9%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $228,553 - $284,165
-296 Reduced 2.78%
10,350 $9.17 Billion
Q2 2024

Aug 06, 2024

BUY
$724.87 - $909.04 $76,836 - $96,358
106 Added 1.01%
10,646 $9.64 Billion
Q1 2024

Apr 17, 2024

BUY
$592.2 - $792.28 $291,362 - $389,801
492 Added 4.9%
10,540 $8.2 Billion
Q4 2023

Apr 17, 2024

BUY
$525.19 - $619.13 $5.28 Million - $6.22 Million
10,048 New
10,048 $5.86 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fox Hill Wealth Management Portfolio

Follow Fox Hill Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Hill Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Fox Hill Wealth Management with notifications on news.